Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR

Mill, Jonathan, Asherson, Philip, Browes, Clare, D'Souza, Ursula, Craig, Ian·2002·American Journal of Medical Genetics
DOI 10.1002/ajmg.b.10948

Cited by (341)

Items 101–200 of 341

  1. Functional polymorphisms in dopamine and serotonin pathway genes
    Ursula M. D’Souza, Ian Craig · 2005 · Human Mutation
  2. Attention Deficit Hyperactivity Disorder
    Jonna Kuntsi, Gráinne McLoughlin, Philip J. Asherson · 2006 · NeuroMolecular Medicine
  3. Resting-State Striato-Frontal Functional Connectivity is Sensitive to DAT1 Genotype and Predicts Executive Function
    Evan M. Gordon, Joseph M. Devaney, Stephanie E. Bean, Chandan J. Vaidya · 2013 · Cerebral Cortex
  4. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families
    S. Bakker, E. M. van der Meulen, N. Oteman, H. Schelleman, Peter L. Pearson, J. Buitelaar, R. Sinke · 2005 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  5. Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort
    Teresa R. Franklin, Ze Wang, Yin Li, Jesse J. Suh, Marina Goldman, Falk W. Lohoff, Jeffrey Cruz, Rebecca Hazan, William Jens, John A. Detre et al. · 2011 · Addiction Biology
  6. Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
    Judith A. Potashkin, José A. Santiago, Bernard M. Ravina, Arthur Watts, Alexey A. Leontovich · 2012 · PLoS ONE
  7. Genotype and ancestry modulate brain's DAT availability in healthy humans
    Shumay, Elena, Chen, John, Fowler, Joanna S., Volkow, Nora D. · 2011 · PLoS ONE
  8. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence
    Andreas Heinz, David A Goldman, J�rgen Gallinat, Günter Schumann, Imke Puls · 2004 · Psychopharmacology
  9. DAT1 Polymorphism Is Associated with Risk Taking in the Balloon Analogue Risk Task (BART)
    Rui Mata, Robin C. Hau, Andreas Papassotiropoulos, Ralph Hertwig · 2012 · PLoS ONE
  10. Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease
    Samir N. Kelada, Paola Costa‐Mallen, Harvey Checkoway, Christopher S. Carlson, Terri Smith‐Weller, Phillip D. Swanson, Gary M. Franklin, W. T. Longstreth, Zahra Afsharinejad, Lucio Guido Costa · 2005 · Pharmacogenetics and Genomics
  11. Polymorphisms in the Dopamine Transporter Gene (SLC6A3/DAT1) and Alcohol Dependence in Humans: A Systematic Review
    Carmen S. van der Zwaluw, Rutger C. M. E. Engels, Jan K. Buitelaar, Robbert Jan Verkes, Barbara Franke, Ron H. J. Scholte · 2009 · Pharmacogenomics
  12. Effect of Dopamine Transporter Gene (SLC6A3) Variation on Dorsal Anterior Cingulate Function in Attention-Deficit/Hyperactivity Disorder
    Ariel B. Brown, J. Biederman, Eve M. Valera, A. Doyle, G. Bush, T. Spencer, M. Monuteaux, E. Mick, S. Whitfield-Gabrieli, N. Makris et al. · 2010 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  13. Genetically determined dopamine availability predicts disposition for depression
    Felten, Andrea, Montag, Christian, Markett, Sebastian, Walter, Nora T., Reuter, Martin · 2011 · Brain and Behavior
  14. Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks
    Brown, Ariel Beth, Biederman, Joseph, Valera, Eve, Makris, Nikos, Doyle, Alysa, Whitfield-Gabrieli, Susan, Mick, Eric, Spencer, Thomas, Faraone, Stephen, Seidman, Larry · 2011 · Psychiatry Research Neuroimaging
  15. Neural response to working memory load varies by dopamine transporter genotype in children
    Melanie Stollstorff, Jennifer H. Foss‐Feig, Edwin H. Cook, Mark A. Stein, William Davis Gaillard, Chandan J. Vaidya · 2010 · NeuroImage
  16. The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition
    Yacubian, J., Büchel, C. · 2009 · Neuroscience
  17. Pharmacogenetics of Nicotine Addiction: Role of Dopamine
    Aryeh I. Herman, Elise E. DeVito, Kevin P. Jensen, Mehmet Sofuoglu · 2014 · Pharmacogenomics
  18. Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity
    Walter Adriani, Emilia Romano, Mariangela Pucci, Esterina Pascale, Luca Cerniglia, Silvia Cimino, Renata Tambelli, Paolo Curatolo, Oleg Granstrem, Mauro Maccarrone et al. · 2017 · European Child & Adolescent Psychiatry
  19. ADHD pharmacogenetics across the life cycle: New findings and perspectives
    E. M. Bruxel, G. C. Akutagava-Martins, Angélica Salatino-Oliveira, V. Contini, C. Kieling, M. Hutz, L. Rohde · 2014 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  20. Gene–lifecourse interaction for alcohol consumption in adolescence and young adulthood: Five monoamine genes
    Guang Guo, Kirk C. Wilhelmsen, Nathan Hamilton · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  21. Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders.
    U. D'Souza, I. Craig · 2008 · Progress in Brain Research
  22. Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin‐dependent patients
    Gilberto Gerra, Luciano Garofano, Caterina Pellegrini, Silvano Bòsari, Amir Zaimovic, Gabriele Moi, Paola Avanzini, Enrica Talarico, Federica Gardini, Claudia Donnini · 2005 · Addiction Biology
  23. Sequence variation in the 3′‐untranslated region of the dopamine transporter gene and attention‐deficit hyperactivity disorder (ADHD)
    Yu Feng, Karen G. Wigg, Rohit Makkar, Abel Ickowicz, Tejaswee Pathare, Rosemary Tannock, Wendy Roberts, MOLLY A. MALONE, James L. Kennedy, Russell James Schachar et al. · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  24. Dopamine Genes and Nicotine Dependence in Treatment-Seeking and Community Smokers
    Andrew W. Bergen, David V. Conti, David Van Den Berg, Won‐Ho Lee, Jinghua Liu, Dalin Li, Nan Guo, Huaiyu Mi, Paul D. Thomas, Christina N. Lessov‐Schlaggar et al. · 2009 · Neuropsychopharmacology
  25. Genetic Determinants of Time Perception Mediated by the Serotonergic System
    Olga Sysoeva, Alexander Tonevitsky, Jiřı́ Wackermann · 2010 · PLoS ONE
  26. Characterization of the 5' flanking region of the growth hormone gene of the marine teleost, gilthead sea bream Sparus aurata: analysis of a polymorphic microsatellite in the proximal promoter
    Ricardo Almuly, Yael Danin‐Poleg, S. Gorshkov, G. Gorshkova, B. Rapoport, M. Soller, Yechezkel Kashi, Bruria Funkenstein · 2005 · Fisheries Science
  27. REVIEW: Cognitive effects of nicotine: genetic moderators
    Aryeh I. Herman, Mehmet Sofuoglu · 2010 · Addiction Biology
  28. The VNTR in complex disorders: The forgotten polymorphisms? A functional way forward?
    Keeley J. Brookes · 2013 · Genomics
  29. Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands.
    M. Das, A. Das Bhowmik, N. Bhaduri, Kanyakumarika Sarkar, Paramita Ghosh, S. Sinha, Anirban Ray, A. Chatterjee, Kanchan Mukhopadhyay · 2011 · Progress in Neuro-psychopharmacology and Biological Psychiatry
  30. An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects
    Se Joo Kim, Y. S. Kim, H. S. Lee, Song Yee Kim, C.-H. Kim · 2006 · Journal of Neural Transmission
  31. Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction
    Maggie M. Sweitzer, Eric C. Donny, A. Hariri · 2012 · Drug and Alcohol Dependence
  32. Relationships Between Angry-Impulsive Personality Traits and Genetic Polymorphisms of the Dopamine Transporter
    Peter R. Joyce, Patrick McHugh, Katrina J. Light, Sarah L. Rowe, Allison L. Miller, Martin Alexander Kennedy · 2009 · Biological Psychiatry
  33. A translational research framework for enhanced validity of mouse models of psychopathological states in depression
    Christopher Robert Pryce, Erich Seifritz · 2010 · Psychoneuroendocrinology
  34. Identification of the mRNA Expression Status of the Dopamine D2 Receptor and Dopamine Transporter in Peripheral Blood Lymphocytes of Schizophrenia Patients
    Liang Liu, Guozhen Yuan, Zaohuo Cheng, Guofu Zhang, Xiaowei Liu, Huifang Zhang · 2013 · PLoS ONE
  35. Effect of Dopamine Transporter Genotype on Intrinsic Functional Connectivity Depends on Cognitive State
    Evan M. Gordon, Melanie Stollstorff, Joseph M. Devaney, Stephanie E. Bean, Chandan J. Vaidya · 2011 · Cerebral Cortex
  36. Integrating genetic, psychopharmacological and neuroimaging studies: A converging methods approach to understanding the neurobiology of ADHD
    Sarah Durston, Kerstin Konrad · 2007 · Developmental Review
  37. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis
    Laura Filonzi, Cinzia Magnani, Anna Maria Lavezzi, Guido Rindi, Stefano Parmigiani, Giulio Bevilacqua, Luigi Matturri, Francesco Nonnis Marzano · 2008 · Neurogenetics
  38. Dopamine transporter polymorphisms affect social approach–avoidance tendencies
    Dorien Enter, Lorenza S. Colzato, Karin Roelofs · 2012 · Genes Brain & Behavior
  39. Dopamine Transporter (SLC6A3) Genotype Impacts Neurophysiological Correlates of Cognitive Response Control in an Adult Sample of Patients with ADHD
    Thomas Dresler, Ann‐Christine Ehlis, Sebastian Heinzel, Tobias Renner, Andreas Reif, Christina G. Baehne, Monika Heine, Andrea Boreatti‐Hümmer, Christian Jacob, Klaus‐Peter Lesch et al. · 2010 · Neuropsychopharmacology
  40. Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans
    Ivo Heitland, Ronald S. Oosting, Johanna M.P. Baas, Stijn A. A. Massar, J. Leon Kenemans, K.B.E. Böcker · 2012 · Cognitive Affective & Behavioral Neuroscience
  41. Dopamine transporter genotype predicts implicit sequence learning
    Jessica R. Simon, Melanie Stollstorff, Lauren C. Westbay, Chandan J. Vaidya, James H. Howard, Darlene V. Howard · 2010 · Behavioural Brain Research
  42. Can we vaccinate against depression?
    G.A.W. Rook, Charles L. Raison, Christopher A. Lowry · 2012 · Drug Discovery Today
  43. Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype
    Alberto Fernández‐Jaén, Sara López‐Martín, Jacobo Albert, Daniel Martı́n Fernández-Mayoralas, Ana Laura Fernández‐Perrone, Mar Jiménez de la Peña, Beatriz Calleja‐Pérez, Manuel Recio Rodríguez, Sonia López-Arribas, Nuria Muñoz Jareño · 2015 · Psychiatry Research Neuroimaging
  44. Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT
    Hideo Yamamoto, Shinichi Arimura, Atsushi Nakanishi, Yasushi Shimo, Yumiko Motoi, Koichi Ishiguro, Koji Murakami, Nobutaka Hattori, Shigeki Aoki · 2017 · Annals of Nuclear Medicine
  45. Fetal growth interacts with multilocus genetic score reflecting dopamine signaling capacity to predict spontaneous sugar intake in children
    Patrícia Pelufo Silveira, Irina Pokhvisneva, Hélène Gaudreau, Leslie R. Atkinson, Alison S. Fleming, Marla B. Sokolowski, Meir S Steiner, James L. Kennedy, Laurette Dubé, Robert D. Levitan et al. · 2017 · Appetite
  46. Eye-blink rate predicts individual differences in pseudoneglect
    Heleen A. Slagter, Richard J. Davidson, Rachel Tomer · 2009 · Neuropsychologia
  47. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
    Grünblatt, Edna, Werling, Anna Maria, Roth, Alexander, Romanos, Marcel, Walitza, Susanne · 2019 · Journal of Neural Transmission
  48. Dopaminergic Gene Polymorphisms Affect Long-term Forgetting in Old Age: Further Support for the Magnification Hypothesis
    Goran Papenberg, Lars Bäckman, Irene E. Nagel, Wilfried Nietfeld, Julia Schröder, Lars Bertram, Hauke R. Heekeren, Ulman Lindenberger, Shu Li · 2013 · Journal of Cognitive Neuroscience
  49. Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia.
    D. Prata, A. Mechelli, M. Picchioni, Cynthia H. Y. Fu, T. Toulopoulou, E. Bramon, M. Walshe, R. Murray, D. Collier, P. McGuire · 2009 · Archives of General Psychiatry
  50. DAT genotype modulates striatal processing and long-term memory for items associated with reward and punishment
    Bianca C. Wittmann, Geoffrey Chern-Yee Tan, John E. Lisman, Raymond J. Dolan, Emrah Düzel · 2013 · Neuropsychologia
  51. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood
    Somkuwar, Sucharita S., Darna, Mahesh, Kantak, Kathleen M., Dwoskin, Linda P. · 2013 · Biochemical Pharmacology
  52. Vaccination strategies for Parkinson disease
    M. Romero-Ramos, M. von Euler Chelpin, Vanesa Sánchez-Guajardo · 2014 · Human Vaccines & Immunotherapeutics
  53. Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females
    Ivo Heitland, J. Leon Kenemans, Ronald S. Oosting, Johanna M.P. Baas, K.B.E. Böcker · 2013 · Behavioural Brain Research
  54. Genome-wide characterization of human minisatellite VNTRs: population-specific alleles and gene expression differences
    Marzieh Eslami Rasekh, Yozen A. Hernandez, Samantha D. Drinan, Juan I. Fuxman Bass, Gary Benson · 2021 · Nucleic Acids Research
  55. A promoter polymorphism (−839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children
    Júlia Pasqualini Genro, Cristian Zeni, Guilherme V. Polanczyk, Tatiana Roman, Luís Augusto Rohde, Mara Helena Hutz · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  56. Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes
    Donatella Marazziti, Giorgio Consoli, I. Másala, Mario Catena Dell’Osso, Stefano Baroni · 2010 · Mini-Reviews in Medicinal Chemistry
  57. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians
    Alexandra Schosser, Karoline Fuchs, Theresa Scharl, Monika Schloegelhofer, Jochen Kindler, Nilufar Mossaheb, Rainer M. Kaufmann, Friedrich Leisch, Siegfried F. Kasper, Werner Sieghart et al. · 2010 · The World Journal of Biological Psychiatry
  58. Molecular imaging of striatal dopamine transporters in major depression—A meta-analysis
    Zongchang Li, Ying Hé, Jinsong Tang, Xiaofen Zong, Maolin Hu, Xiaogang Chen · 2014 · Journal of Affective Disorders
  59. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder
    Xiao-Hui Xu, J. Mill, Bo Sun, Chih-Ken Chen, Yu-Shu Huang, Yu‐Yu Wu, P. Asherson · 2009 · BMC Psychiatry
  60. DAT1 Polymorphism Determines L-DOPA Effects on Learning about Others’ Prosociality
    Christoph Eisenegger, Andreas Pedroni, Jörg Rieskamp, Christian Zehnder, Richard P. Ebstein, Ernst Fehr, Daria Knoch · 2013 · PLoS ONE
  61. Emotional insecurity as a mediator of the moderating role of dopamine genes in the association between interparental conflict and youth externalizing problems
    Patrick T. Davies, Joanna K. Pearson, Dante Cicchetti, Meredith J Martin, Edward Mark Cummings · 2019 · Development and Psychopathology
  62. The Dopamine Transporter Expression Level Differentially Affects Responses to Cocaine and Amphetamine
    Barbara Cagniard, Tatyana D. Sotnikova, Raul R. Gainetdinov, Xiaoxi Zhuang · 2014 · Journal of Neurogenetics
  63. Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake
    Ramos‐Lopez, Omar, Riezu‐Boj, Jose I., Milagro, Fermin I., Martinez, J. Alfredo, MENA Project · 2018 · Brain and Behavior
  64. Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram
    James Warwick, Paul D. Carey, N Cassimjee, Christine Löchner, Sian M. J. Hemmings, Hanlie Moolman-Smook, E. Beetge, Patrick J. Dupont, Dan Joseph Stein · 2012 · Metabolic Brain Disease
  65. Neurobiologie der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS)
    Tobias Banaschewski, Veit Roessner, Henrik Uebel, Aribert Rothenberger · 2004 · Kindheit und Entwicklung
  66. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls
    Shook, Devon, Brady, Colin, Lee, Philip S., Kenealy, Laura, Murphy, Eric R., Gaillard, William D., VanMeter, John W., Cook, Edwin H., Stein, Mark, Vaidya, Chandan J. · 2011 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  67. Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers
    Ana Beatriz Fagundo, Fernando Fernández‐Aranda, Rafael de la Torre, Antonio Verdejo‐García, Roser Granero, Eva Penelo, Manel Gené, Carme Barrot, Cristina García Sánchez, Eva M. Álvarez‐Moya et al. · 2014 · Journal of Psychopharmacology
  68. Attention-Deficit/Hyperactivity Disorder: Advancing on Pharmacogenomics
    Guilherme V. Polanczyk, Cristian Zeni, Júlia Pasqualini Genro, Tatiana Roman, Mara Helena Hutz, Luís Augusto Rohde · 2005 · Pharmacogenomics
  69. Neural coding of computational factors affecting decision making
    Jean‐Claude Dreher · 2013 · Progress in brain research
  70. Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals
    the German Competence Network HIV/AIDS, Anne Horn, Carsten Scheller, Stéfan du Plessis, Gabriele Arendt, Thorsten Nolting, John A. Joska, Sieghart Sopper, Matthias Maschke, Mark Obermann et al. · 2013 · Journal of Neural Transmission
  71. A Dopamine Receptor (DRD2) but Not Dopamine Transporter (DAT1) Gene Polymorphism is Associated with Neurocognitive Development of Mexican Preschool Children with Lead Exposure
    Katarzyna Kordas, Adrienne S. Ettinger, David C. Bellinger, Lourdes Schnaas, Martha María Téllez‐Rojo, Mauricio Hernández‐Ávila, Howard Hu, Robert O. Wright · 2011 · The Journal of Pediatrics
  72. Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population
    Maciej Kazimierz Bieliński, Marcin Jaracz, Natalia Lesiewska, Marta Tomaszewska, Marcin Sikora, Roman Junik, Anna Kamińska, Andrzej Tretyn, Alina Borkowska · 2017 · Neuropsychiatric Disease and Treatment
  73. Relationship between premature ejaculation and genetic polymorphisms of the dopamine transporter gene (SLC6A3)
    Mohammad Reza Safarinejad · 2010 · British Journal of Urology
  74. Antineuronal Antibodies Against Neurotransmitter Receptors and Synaptic Proteins in Schizophrenia: Current Knowledge and Clinical Implications
    Johann Steiner, Kolja Schiltz, Hans‐Gert Bernstein, Bernhard Bogerts · 2015 · CNS Drugs
  75. Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis
    Li, James J., Lee, Steve S. · 2012 · Journal of Child Psychology and Psychiatry
  76. New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
    Pitzianti, Maria Bernarda, Spiridigliozzi, Simonetta, Bartolucci, Elisa, Esposito, Susanna, Pasini, Augusto · 2020 · Frontiers in Psychiatry
  77. Human Genetics and Pharmacology of Neurotransmitter Transporters
    Zhicheng Lin, Bertha Kalifon Madras · 2006 · Handbook of experimental pharmacology
  78. Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene
    Reagan R. Wetherill, Kanchana Jagannathan, Falk W. Lohoff, Ronald N. Ehrman, Charles P. O’Brien, Anna Rose Childress, Teresa R. Franklin · 2012 · Addiction Biology
  79. The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine
    Anne Millar, Dylan Smith, Joëlle Choueiry, Derek J. Fisher, Paul R. Albert, Verner Knott · 2011 · Neuroscience
  80. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
    A. PAsini, L. Sinibaldi, C. Paloscia, Sofia Douzgou, Mariabernarda Pitzianti, E. Romeo, P. Curatolo, A. Pizzuti · 2013 · European journal of paediatric neurology
  81. Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder
    Firoza Mamdani, Marcelo T. Berlim, Marie-Martine Beaulieu, Gustavo Turecki · 2013 · The World Journal of Biological Psychiatry
  82. A Genetic Polymorphism of the Human Dopamine Transporter Determines the Impact of Sleep Deprivation on Brain Responses to Rewards and Punishments
    Stephanie M. Greer, Andrea N. Goldstein‐Piekarski, Brian D Knutson, Matthew P. Walker · 2016 · Journal of Cognitive Neuroscience
  83. Lack of Association between Polymorphisms of the Dopamine Receptor D4 and Dopamine Transporter Genes and Personality Traits in a Korean Population
    Se Joo Kim, Young Shin Kim, Chan‐Hyung Kim, Hong Shick Lee · 2006 · Yonsei Medical Journal
  84. Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans
    Irina Baetu, Nicholas R. Burns, Kristi Urry, Girolamo Giovanni Barbante, Julia B. Pitcher · 2015 · Neurobiology of Learning and Memory
  85. Interaction of Dopamine Transporter Gene and Observed Parenting Behaviors on Attention-Deficit/Hyperactivity Disorder: A Structural Equation Modeling Approach
    James J. Li, Steve S. Lee · 2013 · Journal of Clinical Child & Adolescent Psychology
  86. Pharmacogenetic Role of Dopamine Transporter (SLC6A3) Variation on Response to Disulfiram Treatment for Cocaine Addiction
    June Kampangkaew, Catherine J. Spellicy, Ellen M. Nielsen, Mark J. Harding, An Ye, Sara Hamon, Thomas R. Kosten, David A. Nielsen · 2019 · American Journal on Addictions
  87. Pharmacogenomic Implications of Variants of Monoaminergic-Related Genes in Geriatric Psychiatry
    Paulo R. Shiroma, Yonas E. Geda, David A. Mrazek · 2010 · Pharmacogenomics
  88. Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system
    Satoshi Fuke, Natsumi Minami, Hiroki Kokubo, Ayumu Yoshikawa, Hiroshi Yasumatsu, Noboru Sasagawa, Yumiko Saga, Toshifumi Tsukahara, Shoichi Ishiura · 2006 · Journal of Neuroscience Research
  89. Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics
    Jörn Reese, Adrian Kraschewski, Ion George Anghelescu, Georg Winterer, Lutz G. Schmidt, Jürgen Gallinat, Franz Rüschendorf, Hans Rommelspacher, Catrin Wernicke · 2010 · Psychiatric Genetics
  90. Association between amygdala reactivity and a dopamine transporter gene polymorphism
    Olle Bergman, Fredrik Åhs, Tomas Furmark, Lieuwe Appel, Claes Linnman, V Faria, Massimo Bani, Emilio Merlo Pich, Paolo U. Bettica, Susanne Henningsson et al. · 2014 · Translational Psychiatry
  91. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder
    Mehmet Simsek, Marwan M. Al‐Sharbati, Samir Al‐Adawi, Shyam S Ganguly, Kholuud Lawatia · 2005 · Clinical Biochemistry
  92. The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects
    Mei Yang, Vasish Kavi, Wenfu Wang, Zhimei Wu, Wei Hao · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  93. Temperature and length-dependent modulation of the MH class IIβ gene expression in brook charr (Salvelinus fontinalis) by a cis-acting minisatellite
    Sébastien Croisetière, Louis Bernatchez, Pierre Belhumeur · 2010 · Molecular Immunology
  94. Immunoregulatory role of endogenous catecholamines synthesized by immune cells.
    Jian‐Lan Jiang, Yihua Qiu, Yu-Ping Peng, Jianjun Wang · 2006 · PubMed
  95. The potential role of myostatin and neurotransmission genes in elite sport performances
    Laura Filonzi, N Franchini, Marina Vaghi, Stefania Chiesa, Francesco Nonnis Marzano · 2015 · Journal of Biosciences
  96. Functional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants
    Matthew Hill, Richard Anney, Michael Gill, Ziarih Hawi · 2009 · The Pharmacogenomics Journal
  97. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics
    Darko Turic · 2010 · Pharmacogenomics and Personalized Medicine
  98. The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and borderline personality disorder in female heroin-dependent Chinese subjects
    Mei Yang, Jules Mamy, Qiang Wang, Yanhui Liao, Vasish Seewoobudul, Shui-Yuan Xiao, Wei Hao · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  99. Teacher–student relationships and adolescent behavioral engagement and rule-breaking behavior: The moderating role of dopaminergic genes
    Steven De Laet, Hilde Colpin, Karla G. Van Leeuwen, Wim Van Den Noortgate, Stephan J. Claes, Annelies Janssens, Luc Goossens, Karine Verschueren · 2016 · Journal of School Psychology
  100. Contribution of allelic variations in transporters to the phenotype of drug response
    Julia Kirchheiner, Dirk Gründemann, Edgar Schömig · 2006 · Journal of Psychopharmacology